AbbVie Juvmo FDA Approved: Parkinson's Breakthrough | Pharma and Biotech Daily

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent updates in these sectors have highlighted significant scientific advancements, regulatory milestones, and promising clinical trial results that could impact patient care and drug development. One of the standout developments is the FDA's approval of AbbVie's Juvmo, marking a new chapter in Parkinson's disease treatment. As the first selective D1/D5 recep...